Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA)
- 409 Downloads
To evaluate the antibacterial efficacy of photo-activated riboflavin using Ultraviolet A (UVA) on three bacterial strains commonly detected in keratitis.
Three bacterial strains (Staphylococcus epidermidis, Staphylococcus aureus and Pseudomonas aeruginosa) were cultured on blood/hematin–agar plates and dispersed in PBS. Dispersion was done of 10 μl of bacterial stock-solutions in 90 μl of RPMI, where different riboflavin molarities had been added, to achieve a bacterial concentration of 1-4 × 10 4/ml. Riboflavin end molarities before illumination were 0, 100, 200, 300 and 400 μM. Each solution had a negative control. The solutions were illuminated with UVA (365 nm) for 30 minutes (5.4 J/cm2) and then continued for a total time of 60 minutes (10.8 J/cm2). A count of CFU was conducted after incubation and results compared.
In all tested strains, a slight decrease of bacteria was seen when exposed to UV for 30 minutes. A doubling of the UV dose showed a marked decrease of bacterial count in all bacteria tested. The combination of UV and riboflavin showed a more extensive reduction of CFU, confirming an interaction effect between UV and riboflavin.
Riboflavin photo-activation using UVA (365 nm) can achieve an extensive eradication of bacteria, and the combination is more potent in reducing bacterial number than UV alone.
KeywordsRiboflavin UVA Keratitis Cross-linking Antimicrobial
- 17.Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T (2006) Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract Refract Surg 32:837–845CrossRefPubMedGoogle Scholar
- 25.Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49:3402–3408CrossRefPubMedGoogle Scholar
- 32.Betanzos-Cabrera G, Juárez-Verdayes MA, González-González G, Cancino-Díaz ME, Cancino-Díaz JC (2009) Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic Res 42:43–48CrossRefPubMedGoogle Scholar